Smith & Nephew Plc Share Price Deutsche Boerse AG

Equities

NPW1

GB0009223206

Medical Equipment, Supplies & Distribution

Real-time Estimate Tradegate 12:30:32 17/05/2024 am IST 5-day change 1st Jan Change
11.99 EUR +1.46% Intraday chart for Smith & Nephew Plc +1.67% -4.05%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 581.72Cr 535.26Cr 49TCr Sales 2025 * 612.06Cr 563.18Cr 51TCr Capitalization 1.13TCr 1.04TCr 94TCr
Net income 2024 * 54Cr 50Cr 4.51TCr Net income 2025 * 69Cr 64Cr 5.79TCr EV / Sales 2024 * 2.39 x
Net Debt 2024 * 255.55Cr 235.14Cr 21TCr Net Debt 2025 * 222.95Cr 205.14Cr 19TCr EV / Sales 2025 * 2.21 x
P/E ratio 2024 *
21.9 x
P/E ratio 2025 *
16.8 x
Employees 18,452
Yield 2024 *
2.96%
Yield 2025 *
3.32%
Free-Float 99.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.46%
1 week+1.67%
Current month+3.31%
1 month+6.71%
3 months-8.53%
6 months+0.89%
Current year-4.05%
More quotes
1 week
11.60
Extreme 11.6
11.90
1 month
11.15
Extreme 11.15
11.90
Current year
11.11
Extreme 11.11
13.47
1 year
10.21
Extreme 10.21
15.00
3 years
10.21
Extreme 10.21
18.91
5 years
10.21
Extreme 10.21
24.20
10 years
10.21
Extreme 10.21
24.20
More quotes
Managers TitleAgeSince
Chief Executive Officer - 01/22/01
Director of Finance/CFO 56 01/12
Compliance Officer - 01/99/01
Members of the board TitleAgeSince
Director/Board Member 65 01/17/01
Director/Board Member 62 14/23/14
Chairman 63 26/23/26
More insiders
Date Price Change
16/24/16 11.86 +0.34%
15/24/15 11.82 +1.33%
14/24/14 11.66 -2.02%
13/24/13 11.9 +2.59%
10/24/10 11.6 -0.51%

Delayed Quote Deutsche Boerse AG, May 16, 2024 at 11:34 am IST

More quotes
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows: - orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders); - sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.; - wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc. The United States accounts for 53.7% of net sales.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
12.92 USD
Average target price
16.35 USD
Spread / Average Target
+26.49%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW